Article
CCR5Δ32 mutations do not determine COVID-19 disease course.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 1 Apr 2021
Bernas Stefanie N, Baldauf Henning, Wendler Sarah, Heidenreich Falk, Lange Vinzenz, Hofmann Jan A, Sauter Jürgen, Schmidt Alexander H, Schetelig Johannes
Abstract excerpt
OBJECTIVES: To determine the impact of the 32 bp deletion (CCR5Δ32) in the coding region of the C-C chemokine receptor 5 (CCR5) on the risk of contracting SARS-CoV-2 and severe COVID-19. METHODS: Cross-sectional study among stem cell donors registered with DKMS in Germany. Genetic information was linked to self-reported COVID-19 outcome data. Multivariable regression models were fitted to determine the risk of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
